1-5 of 5
Srikanth Gajavelli, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health-Related Quality-of-Life Outcomes in Patients with Classical Hodgkin Lymphoma: A Prospective, Observational Study in US Oncology Practices

Jakub Svoboda, MD, Philippe Armand, MD PhD, Fiona Taylor, Xiaowu Sun, Alejandro Moreno-Koehler, Srikanth Gajavelli, MD, Derek Peterson, Clara Chen, PhD BS, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2192.
https://doi.org/10.1182/blood-2019-123980
Published: 2019
Journal Articles

Cardiovascular Hospitalization in Patients Treated with Dasatinib or Nilotinib in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients in Routine Clinical Practice

Michael J. Mauro, MD, Clara Chen, PhD BS, MS, Jorge E. Cortes, MD, Carlo Gambacorti-Passerini, MD, Ginny P Sen, MPH, Srikanth Gajavelli, MD, Catherine Davis, Mauricette Michallet, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4258.
https://doi.org/10.1182/blood-2018-99-115903
Published: 2018
Journal Articles

Dosing Patterns of Dasatinib Use in Simplicity, an Observational Study in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients (pts) in Routine Clinical Practice

Jorge E. Cortes, MD, Clara Chen, PhD BS, MS, Michael J. Mauro, MD, Ginny P Sen, MPH, Srikanth Gajavelli, MD, Catherine Davis, PharmD, Stuart L. Goldberg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1730.
https://doi.org/10.1182/blood-2018-99-118119
Published: 2018
Journal Articles

Outcomes of Classical Hodgkin Lymphoma in US Hematology Practices: Initial Data from a Prospective Real-World Study

Christopher A. Yasenchak, MD, Jakub Svoboda, MD, Sarah M Larson, MD, Don A Stevens, MD, Srikanth Gajavelli, MD, Trong Kim Le, Philippe Armand, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5626.
https://doi.org/10.1182/blood.V130.Suppl_1.5626.5626
Published: 2017
Journal Articles

Cytogenetic and Molecular Responses after 2 Years of Tyrosine Kinase Inhibitor (TKI) Treatment in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice

Jorge E. Cortes, MD, Stuart L. Goldberg, MD, Mauricette Michallet, MD PhD, Rüdiger Hehlmann, MD, Bengt Simonsson, MD, Michael J. Mauro, MD, Loretta A. Williams, PhD MSN, BSN, BA, Teresa Zyczynski, PharmD, MPH, MBA, BSPharm, Ginny P Sen, MPH, Aimee Foreman, MA, Srikanth Gajavelli, MD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2894.
https://doi.org/10.1182/blood.V130.Suppl_1.2894.2894
Published: 2017